Caracemide is a novel anticancer agent derived from a hydroxamic acid and has demonstrated to produce severe central nervous system (CNS) toxicity
Chemical Name: dimethyl[(1S)-3-(naphthalen-1-yloxy)-1-phenylpropyl]amine hydrochloride
3R)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]hexanoyl]amino]-5-oxopentanoic acid 2
Chemical Name: (2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[(2-naphthalen-2-ylacetyl)amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-phosphonooxyphenyl)propanoic acid
Theaflavin 3, 3'-digallate Catalog No.:M18282-C Caracemide is a novel anticancerTheaflavin 3,3' digallate (TF 3) is a potent Zika virus (ZIKV) protease inhibitor with an IC50 of 2. 3 M. Theaflavin 3,3' digallat directly binds to ZIKVpro (Kd=8. 86 M) and inhibits ZIKV replication. Theaflavin 3,3' digallat inhibits the activity of gp41 and NS2B 3 protease and has antiviral activity against HSV and HIV 1. Theaflavin 3,3' digallate, the typical pigment in black tea, is a potent antitumor agent. Product information CAS Number: 30462